Clinical oncology innovation
CancerFree Biotech
Aligned with oncology research, patient-centred translational pathways, and advanced therapeutic innovation.
International conference • Academic & industry participation • Limited to 120 participants
|
Dates: 20–22 January 2027
|
City: Singapore
Partnership • Sponsorship • Exhibition • Industry engagement
ECTMBICS 2027 Partners, Sponsors & Exhibitors
ECTMBICS 2027 welcomes companies, research organisations, healthcare institutions, professional associations, technology providers, startups and industry partners that wish to engage with an international audience across translational medicine, clinical research, biotechnology, pharmaceutical innovation, digital health, precision medicine and healthcare transformation.
Conference audience
Research + Clinical + Industry
Researchers, clinicians, academics, biotech and pharma professionals, healthcare innovators, students, and international delegates.
Partnership value
Visibility + engagement
Build visibility, demonstrate relevant solutions, engage with scientific audiences, and develop new academic and industry connections.
Why partner with ECTMBICS?
Partnering with ECTMBICS positions your organisation alongside professional dialogue on translational medicine, biotech innovation, clinical strategy, digital health, and healthcare implementation.
Visibility
Brand presence across priority touchpoints
Programme, website, exhibition, networking, and conference communications
Engagement
Engagement with researchers, clinicians & industry
Relevant conversations, product awareness, collaboration and networking
Positioning
Association with clinical and biotech innovation
Translational medicine, pharma strategy, digital health, and healthcare impact
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Strategic partnership pathways
Visibility • exhibition • networking • scientific & industry engagement
Partnership focus
Flexible participation options for organisations seeking meaningful visibility, scientific engagement, exhibition presence, and long-term collaboration.
Brand positioning
Conference visibility
Networking
Professional networking
Themes
Clinical + biotech + healthcare innovation
Support
Tailored collaboration scope
Who we work well with
We welcome organisations whose technologies, services, research activity or professional interests align with the congress themes and can contribute value to participants across academia, healthcare and industry.
Clinical & research partners
Hospitals, clinical research organisations, medical centres, academic research institutes, and translational medicine groups.
Biotech & pharma organisations
Biotechnology companies, pharmaceutical groups, therapeutic platforms, diagnostics innovators, and commercialisation teams.
Digital health & data ecosystems
AI healthcare platforms, digital medicine groups, clinical data companies, precision medicine and decision-support innovators.
Associations, investors & innovation networks
Healthcare investors, accelerators, scientific associations, professional societies, regulatory networks, innovation hubs, universities and industry groups.
What partnership can include
Participation can be tailored according to organisational goals, available space, programme relevance, and the type of engagement requested.
Brand visibility
Website and programme recognition, event signage where applicable, selected communication placements, and on-site brand presence according to the agreed package.
Scientific & industry engagement
Opportunities may include approved industry sessions, technical demonstrations, panel participation, innovation showcases, or educational activities where appropriate and clearly identified.
Exhibition & delegate engagement
Exhibition tables or display space may be available for organisations to present technologies, services, research tools, platforms, or institutional capabilities to delegates.
Custom collaboration opportunities
Tailored arrangements may be considered for universities, healthcare institutions, biotechnology and pharmaceutical companies, startups, research-service providers, professional associations and innovation networks.
Our partnership approach
01
Relevance first
We prioritise alignment over volume.
02
Participant value
Partnership activity should add useful scientific, clinical, professional or technical value to the conference experience.
03
Transparent engagement
Sponsored or industry-supported activities should be clearly identified and remain separate from independent scientific review and editorial decisions.
Partner network
ECTMBICS 2027 works with organisations across biotechnology, clinical translation, digital health, diagnostics, therapeutics and healthcare technology. The organisations shown below are presented within the conference partner network based on the current website content and may participate through collaboration, visibility, exhibition, knowledge exchange or other agreed forms of engagement.
AI diagnostics & pathology
Qritive
Connected to AI-supported clinical diagnostics, digital pathology, workflow intelligence, and healthcare decision support.
Medical AI & imaging
VinBrain
Relevant to AI-powered medical imaging, healthcare data platforms, and scalable clinical implementation.
Diagnostics & biosensing
Nanotis
Supports the congress focus on biosensing, diagnostic technologies, and practical health innovation pathways.
Healthcare technology collaboration
Gyder
Positioned within the broader digital health, healthcare technology, and innovation partnership landscape.
Applied science & innovation
Intermag
Represents interdisciplinary innovation connected to applied science, research translation, and industry-facing collaboration.
Strategic technology partner
Armastec
Included as a technology-oriented collaboration partner supporting cross-sector visibility and professional engagement.
Integrated partner visibility
The organisations above are presented as part of the ECTMBICS 2027 partner network. Individual participation may differ by organisation and may include partnership, exhibition, sponsorship, knowledge exchange, technical engagement, networking, or other agreed activities. Inclusion on this page does not imply endorsement of products or services by the scientific committee.